Skip to main content
SpringerLink
Log in
Book cover

The Behavioral Neuroscience of Drug Discrimination pp 319–328Cite as

A Prospective Evaluation of Drug Discrimination in Pharmacology

  • Chapter
  • First Online:

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 39))

Abstract

As investigators, we use many methodologies to answer both practical and theoretical questions in our field. Occasionally, we must stop and collect the latest findings or trends and then look forward to where our ideas, findings, and hypotheses may take us. Similar to volumes that were published in previous years on drug discrimination (Glennon and Young, Drug discrimination applications to medicinal chemistry and drug studies. Wiley, Hoboken, 2011; Ho et al., Drug discrimination and state dependent learning. Academic Press, New York, 1978), this collection in Current Topics in Behavioral Neurosciences serves as a current analysis of the continued value of the drug discrimination procedure to the fields of pharmacology, neuroscience, and psychology and as a stepping stone to where drug discrimination methodology can be applied next, in both a practical and theoretical sense. This final chapter represents one investigator’s perspective on the utility and possibilities for a methodology that she fell in love with over 30 years ago.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Allen DC, Ford MM, Grant KA (2017) Cross-species translational findings in the discriminative stimulus effects of ethanol. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2017_2

  • Balster RL (1991) Discriminative stimulus properties of phencyclidine and other NMDA antagonists. In: Glennon RA, Järbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph 116. US Government Printing Office, Washington, pp 163–180

    Google Scholar 

  • Becker GL, Gerak LR, Koek W, France CP (2008) Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys. Psychopharmacology 201(3):373–382

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Berquist MD 2nd, Fantegrossi WE (2017) Discriminative stimulus effects of psychostimulants. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2017_5

  • Bolin BL, Alcorn JL 3rd, Reynolds AR, Lile JA, Stoops WW, Rush CR (2016) Human drug discrimination: elucidating the neuropharmacology of commonly abused illicit drugs. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_10

  • Butelman ER, Kreek MJ (2016) Discriminative stimulus properties of opioid ligands: progress and future directions. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_9

  • Colpaert FC (2011) Drug discrimination: a perspective. In: Glennon R, Young R (eds) Drug discrimination applications to medicinal chemistry and drug studies. Wiley, Hoboken

    Google Scholar 

  • Gauvin DV, Holloway FA (1991) Cross-generalization between an ethologically [correction of ecologically] relevant stimulus and a pentylenetetrazole-discriminative cue. Pharmacol Biochem Behav 39(2):521–523

    Article  CAS  PubMed  Google Scholar 

  • Goodwin AK, Baker LE (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (±)-MDMA in rats. Exp Clin Psychopharmacol 8:415–423

    Article  CAS  PubMed  Google Scholar 

  • Harper DN, Crowther A, Schenk S (2011) A comparison of MDMA and amphetamine in the drug discrimination paradigm. Open Addiction J 4:22–23

    Article  CAS  Google Scholar 

  • Harris CM, Emmett-Oglesby MW, Robinson NG, Lal H (1986) Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazol (PTZ). Psychopharmacology 90(1):85–89

    Article  CAS  PubMed  Google Scholar 

  • Jewett DC, Lefever TW, Flashinski DP, Koffarnus MN, Cameron CR, Hehli DJ, Grace MK, Levine AS (2006) Intraparaventricular neuropeptide Y and ghrelin induce learned behaviors that report food deprivation in rats. Neuroreport 17(7):733–737

    Article  CAS  PubMed  Google Scholar 

  • Jewett DC, Hahn TW, Smith TR, Fiksdal BL, Wiebelhaus JM, Dunbar AR, Filtz CR, Novinska NL, Levine AS (2009) Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation. Psychopharmacology 203(2):453–459

    Article  CAS  PubMed  Google Scholar 

  • Jones HE, Bigelow GE, Preston KL (1999) Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure. J Pharmacol Exp Ther 289(3):1350–1361

    CAS  PubMed  Google Scholar 

  • Jung ME, Lal H, Gatch MB (2002) The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments. Neurosci Biobehav Rev 26(4):429–439

    Article  CAS  PubMed  Google Scholar 

  • Kelly TH, Emurian CS, Baseheart BJ, Martin CA (1997) Discriminative stimulus effects of alcohol in humans. Drug Alcohol Depend 48(3):199–207

    Article  CAS  PubMed  Google Scholar 

  • Koek W (1999) N-methyl-D-aspartate antagonists and drug discrimination. Pharmacol Biochem Behav 64:275–281

    Article  CAS  PubMed  Google Scholar 

  • Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL, Henningfield JE, Goldberg SR (1991) The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther 259(3):1165–1173

    CAS  PubMed  Google Scholar 

  • McMahon LR (2015) The rise (and fall?) of drug discrimination research. Drug Alcohol Depend 151:284–288

    Article  PubMed  PubMed Central  Google Scholar 

  • Mori T, Suzuki T (2016) The discriminative stimulus properties of hallucinogenic and dissociative anesthetic drugs. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_29

  • Negus SS, Banks ML (2016) Pharmacokinetic-pharmacodynamic (PKPD) analysis with drug discrimination. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_36

  • Overton DA (1982) Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm. Psychopharmacology 76:385–395

    Article  CAS  PubMed  Google Scholar 

  • Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH (2017) Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Neuropharmacology 125:80–86

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Porter JH (2011) Discriminative stimulus properties of receptor antagonists. In: Glennon R, Young R (eds) Drug discrimination applications to medicinal chemistry and drug studies. Wiley, Hoboken, pp 287–322

    Chapter  Google Scholar 

  • Porter JH, Webster KA, Prus AJ (2017) Translational value of drug discrimination with typical and atypical antipsychotic drugs. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2017_4

  • Porter JH, Prus AJ, Overton DA (2018) Drug discrimination: historical origins, important concepts, and principles. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2018_40

  • Prus AJ, Porter JH (2016) The discriminative stimulus properties of drugs used to treat depression and anxiety. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_27

  • Recker MD, Higgins GA (2004) The opioid receptor like-1 receptor agonist Ro 64-6,198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue. J Pharmacol Exp Ther 311:652–658

    Article  CAS  PubMed  Google Scholar 

  • Reynolds GS (1961) Attention in the pigeon. J Exp Anal Behav 4:203–208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Riley AL, Clasen MM, Friar MA (2016) Conditioned taste avoidance drug discrimination procedure: assessments and applications. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_8

  • Rosecrans JA, Young R (2017) Discriminative stimulus properties of S(−)-nicotine: “a drug for all seasons”. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2017_3

  • Schechter MD (1995) Discriminative stimulus properties of isradipine: effect of other calcium channel blockers. Pharmacol Biochem Behav 50(4):539–543

    Article  CAS  PubMed  Google Scholar 

  • Shelton KL (2016) Discriminative stimulus effects of abused inhalants. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_22

  • Stewart JL, McMahon LR (2010) Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. J Pharmacol Exp Ther 334(1):347–356

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stolerman IP, Mariathasan EA, White JA, Olufsen KS (1999) Drug mixtures and ethanol as compound internal stimuli. Pharmacol Biochem Behav 64(2):221–228

    Article  CAS  PubMed  Google Scholar 

  • Vanecek SA, Young AM (1995) Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behav Pharmacol 6(7):669–681

    Article  CAS  PubMed  Google Scholar 

  • Walker EA, Picker MJ, Granger A, Dykstra LA (2004) Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther 310(1):150–158

    Article  CAS  PubMed  Google Scholar 

  • Wiley JL, Owens RA, Lichtman AH (2016) Discriminative stimulus properties of phytocannabinoids, endocannabinoids, and synthetic cannabinoids. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2016_24

  • Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY (1997) Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 282(2):676–684

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA

    Ellen A. Walker

Authors
  1. Ellen A. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ellen A. Walker .

Editor information

Editors and Affiliations

  1. Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA

    Joseph H. Porter

  2. Department of Psychological Science, Northern Michigan University, Marquette, MI, USA

    Adam J. Prus

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Walker, E.A. (2018). A Prospective Evaluation of Drug Discrimination in Pharmacology. In: Porter, J.H., Prus, A.J. (eds) The Behavioral Neuroscience of Drug Discrimination. Current Topics in Behavioral Neurosciences, vol 39. Springer, Cham. https://doi.org/10.1007/7854_2018_59

Download citation

Publish with us

Policies and ethics

Search

Navigation